Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-030648
Filing Date
2025-10-07
Accepted
2025-10-07 16:15:04
Documents
2
Period of Report
2025-10-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4725
2 EXHIBIT 24 jarrettdisbrowpoa.htm EX-24 10608
  Complete submission text file 0001437749-25-030648.txt   17053
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Issuer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address
Disbrow Jarrett (Reporting) CIK: 0001640724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38247 | Film No.: 251380009